5) PI3Ki has been found synergistic effects with HDACi in vitro and in vivo in non-Hodgkin lymphoma (NHL), via induction of DNA damage, downregulation of Mcl-1, and upregulation of Bim protein [68]. The gene discussed is BCL2L11; the disease is non-Hodgkin lymphoma.